In new Regeneron deal for COVID drug, White House imposes price limits for first time

By STAT News
| September 14, 2023

A groundbreaking clause in a new deal between HHS and Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers' list prices.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...